A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples